Product Wiki · Recalls · EU Safety Gate (RAPEX)

Craft Crazy - Kids Stickers — recall A12/1170/15

EU Safety Gate (RAPEX) · Norway · 2015-09-25 · Serious risk

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
A12/1170/15
Date of alert
2015-09-25
Country / jurisdiction
Norway
Risk level
Serious risk
Risk type
Chemical, Environment
Brand
Nille
Product category
Toys
Product type
Stickers
Reported risk: The stickers contain di-(2-ethylhexyl) phthalate (DEHP) (measured value: 13.6% by weight). DEHP may harm the health of children, causing possible damage to the reproductive system. The stickers also contain di-isononyl phthalate (DINP) (measured value: 0.9% by weight).According to the REACH Regulation, the phthalates DEHP, DBP and BBP are prohibited in all toys and childcare articles, while phthalates DINP, DIDP and DNOP are prohibited in toys or childcare articles that can be placed in the mouth by children. Furthermore, the amount of cadmium in the stickers is too high (measured value: 440 mg/kg). Cadmium is harmful to human health, because it accumulates in the body and can damage organs and it may cause cancer.The product does not comply with REACH Regulation.The product poses an environmental risk (chemical pollution) due to the presence of short chain chlorinated paraffin (SCCP) (measured value 1.5%). The product does not comply with the Commission Regulation on persistent organic pollutants (POP Regulation).
Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/177060

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.